ABESTRACT:
Introduction & Objective: Hepatitis C virus (HCV)-infection leads to development of chronic hepatitis, liver cirrhosis and hepatoma. Both the liver damage and extrahepatic manifestation of HCV are immune-mediated. Since HCV is an RNA virus, a role for toll like receptor 7 (TLR7) in the immune response against HCV is likely. The aim of the present study was to determine the frequency of C.32T allele of TLR-7 in general and chronic HCV hepatitis, and its effect on treatment of HCV.
Materials & Methods: This case –control study was carried out on 154 patients of chronic hepatitis C in 2008-2009. The patients were selected from referrals to Hepatitis clinic at Shahid Motahari Polyclinic affiliated to Shiraz University of Medical Sciences, Shiraz, Iran which had indication of treatment. The patients were randomly selected according to inclusion and exclusion criteria. Control group consisted of 225 healthy subjects. The frequency of c.32T allele of TLR-7 was determined in154 patients with chronic HCV-infection, and in 225 healthy controls. Treatment with interferon-alpha and ribavirin was performed after genotype determination. Sustained virologic response (SVR) and end treatment response (ETR) were determined and effect of c.32T allele of TLR-7 on outcomes of treatment was evaluated.
Results: The frequency of c.32T allele of TLR-7 in patients with chronic hepatitis C was 15.33% in male, 14.67% in female and totally 15.2%. The frequency of c.32T allele of TLR-7 in healthy control group was 16.24% in male, 10.3% in female and totally 14.67%.
The rate of Sustained Virologic Response (SVR) was 75%, but in patients that had c.32T allele of TLR-7, SVR was 55%
(p=0.046).
Conclusion: c.32A>T single nucleotide polymorphism of TLR-7, by impairment of TLR-7 function, can be considered among host factors that had unfavorable effect on response rate to treatment of patients with chronic HCV hepatitis.
Keywords: Hepatitis C virus, Toll like receptor 7 (TLR7), Sustained Virologic Response, End treatment response (ETR)
Taghavi S, Damangir H, Kamali Sarvestani E, Eshraghian A. Relation between C.32 A>T Polymorphism In TLR7 and Response to Treatment in Chronic HCV-Infection. armaghanj 2009; 14 (2) :105-116 URL: http://armaghanj.yums.ac.ir/article-1-605-en.html